Women should have access to the medicines they need to live their best and fullest lives. Medicines360 is helping in a unique way.


Latest Updates


Defying Definitions and Breaking Down Barriers: Lessons from Medicines360’s Nonprofit Journey

Medicines360 has the unique distinction of being the longest-standing nonprofit pharmaceutical organization that has product available in the U.S. market. Its inception was an industry innovation, and its survival has required it to push boundaries and defy traditional definitions — all in service of improving health equity. For the Medicines360’s team, the value of this […]

Read More >
Press Releases

In the Wake of Supreme Court Decision, Medicines360 Stands With Women

Nonprofit women’s health pharmaceutical organization affirms commitment to expand access to birth control in U.S San Francisco, CA – Today, following the Supreme Court’s release of the majority decision in  Dobbs v. Jackson Women’s Health Organization, Medicines360 CEO Tina Raine-Bennett, MD, MPH, released the following statement: “At Medicines360, our work is driven by our deep […]

Read More >
Press Releases

Medicines360 Applauds HELP Committee for Including Critical Amendments on Nonprofit Pharma in Legislation Headed to Senate Floor  

Committee member Senator Rosen has been a leading voice supporting the nonprofit pharmaceutical model San Francisco, CA –  Earlier this week, the United States Senate Health, Education, Labor, and Pensions (HELP) Committee advanced the Food and Drug Administration Safety and Landmark Advancements (FDASLA Act/ S. 4348) Act to the full Senate floor with broad bipartisan […]

Read More >
more updates

how we work

We’re reinventing the pharma business model: we identify areas in women’s health where patients face limited choices, develop medicines that expand women’s options and make them available in ways that close gaps in access.


We believe women should have access to medicines, regardless of their diverse needs. As we choose products for development and study them in robust clinical trials, we tackle areas where many women struggle with limited medicine choices.